Osvobození vyplatit Opravdu teva reuters Stanoveno okres Specialita
Israeli unions warn Teva Pharm over plan to close Ashdod plant
US court invalidates key TEVA drug patent
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
TEVA.N - | Stock Price & Latest News | Reuters
Israeli Unions Warn Teva Pharm Over Plan to Close Ashdod Plant
Teva Names Interim CEO, New Chairman As Vigodman Steps Down
Teva Pharm bets on neurology drugs for growth as Q1 profit misses | Reuters
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
GSK's $235 million verdict revived against Teva, again | Reuters
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva to pay up to $4.2 billion in U.S. to settle opioid claims | Reuters
Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
Teva may pay as much as $3.6 billion in opioid settlement | Business Insurance
TEVA.TA - | Stock Price & Latest News | Reuters
Teva Pharmaceutical | PBS NewsHour
Teva's proposed settlement could cost drugmaker pennies on the dollar - The Jerusalem Post
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech
Biden admin urges Supreme Court to hear 'skinny labels' case between Teva, GSK | Reuters
Teva in Talks to Buy Allergan's Generic-Drug Unit - WSJ
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva, Viatris win U.S. appeal in patent fight over Parkinson's drug | Reuters
Teva and Eli Lilly scrap over migraine drug rights — MedWatch
Teva CEO Exits Amid Crisis of Confidence at Drugmaker
AstraZeneca Slumps on Report CEO Is Heading to Teva
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business